Proportion of the target population who received a 3rd dose of in Central America
Central America: Proportion of the target population who received a 3rd dose of was 80.0% in 2024. ▲ Rising
Proportion of the target population who received a 3rd dose of in Central America, 2008–2024
Source: United Nations Statistics Division, SDG Global Database.
Analysis
In 2024, proportion of the target population who received a 3rd dose of in Central America stood at 80.0%.
That represents a change of down 11.1% over ten years.
Over the whole period, proportion of the target population who received a 3rd dose of in Central America peaked at 92.0% in 2015 and was at its lowest, 10.0%, in 2008.
That places Central America 12th out of 31 groups with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 17 years of available data.
Proportion of the target population who received a 3rd dose of in Central America, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 10.0% | — |
| 2009 | 33.0% | +230.0% |
| 2010 | 69.0% | +109.1% |
| 2011 | 82.0% | +18.8% |
| 2012 | 86.0% | +4.9% |
| 2013 | 85.0% | -1.2% |
| 2014 | 90.0% | +5.9% |
| 2015 | 92.0% | +2.2% |
| 2016 | 92.0% | +0.0% |
| 2017 | 92.0% | +0.0% |
| 2018 | 89.0% | -3.3% |
| 2019 | 88.0% | -1.1% |
| 2020 | 80.0% | -9.1% |
| 2021 | 83.0% | +3.8% |
| 2022 | 84.0% | +1.2% |
| 2023 | 80.0% | -4.8% |
| 2024 | 80.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 21.5% | 10.0% | 33.0% | 2 |
| 2010s | 86.5% | 69.0% | 92.0% | 10 |
| 2020s | 81.4% | 80.0% | 84.0% | 5 |
Countries ranked near Central America
- 11 Bangladesh 97.0% compare
- 11 Luxembourg 97.0% compare
- 11 Republic of Korea 97.0% compare
- 11 Tunisia 97.0% compare
- 13 Democratic Republic of the Congo 63.0% compare
- 15 Andorra 96.0% compare
- 15 Denmark 96.0% compare
- 15 El Salvador 96.0% compare
- 15 France 96.0% compare
- 15 Ghana 96.0% compare
- 15 Kuwait 96.0% compare
- 15 Mongolia 96.0% compare
- 15 Nepal 96.0% compare
- 15 Qatar 96.0% compare
- 15 Saudi Arabia 96.0% compare
- 15 Slovakia 96.0% compare
- 15 Uruguay 96.0% compare
More infrastructure data for Central America
- Proportion of children moderately or severely stunted 17.2% (2024)
- Proportion of children moderately or severely overweight 7.0% (2024)
- Proportion of the target population who received 3 doses of 80.0% (2024)
- Developing countries’ and least developed countries’ share of global 3.1% (2024)
- Developing countries’ and least developed countries’ share of global 2.8% (2024)
- Developing countries’ and least developed countries’ share of global 1.2% (2024)
- Developing countries’ and least developed countries’ share of global 1.2% (2024)
- Proportion of population practicing open defecation, by urban/rural 0.4% (2024)
- Total official flows for infrastructure, by recipient countries 3,586 (2024)
- Total reserves in months of imports 3.91 (2024)
Frequently asked questions
- What is proportion of the target population who received a 3rd dose of in Central America?
- Proportion of the target population who received a 3rd dose of in Central America was 80.0% in 2024, according to United Nations Statistics Division, SDG Global Database.
- What is the highest proportion of the target population who received a 3rd dose of recorded in Central America?
- The highest recorded value was 92.0% in 2015.
- What is the lowest proportion of the target population who received a 3rd dose of recorded in Central America?
- The lowest recorded value was 10.0% in 2008.
- How does Central America rank for proportion of the target population who received a 3rd dose of?
- Central America ranks 12th out of 31 groups with data for 2024.
- Is proportion of the target population who received a 3rd dose of rising or falling in Central America?
- Over the last ten years it is down 11.1%. The long-run trend across the full record is rising.
- Where does this Central America data come from?
- The figures come from United Nations Statistics Division, SDG Global Database, published as part of Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 17 observations, free to reuse under UN SDG Global Database (open, attribution requested).